EOLS - MCAP CO - Evolus, Inc.

The price history of Evolus, Inc. (EOLS) reflects the development of a business capturing the aesthetics niche through affordable neurotoxins and digital marketing. The current metric stands at 0.53. Company revenues are heavily dependent on consumer demand and are subject to quarterly fluctuations. Simultaneously, the company is implementing software for documentation automation and predictive analytics, complementing targeted tests of physical robots in medical centers.

Evolus, Inc. (EOLS) market share in the aesthetic neurotoxin sector directly impacts the business's investment attractiveness. The company's market capitalization is calculated as the product of the total number of shares and the closing price, reflecting the aggregate value of the enterprise. By analyzing the size of the company's market capitalization, an investor distinguishes the long-term trend from short-term noise. Stable sales and supply chain control minimize the volatility of this metric. A high valuation scale provides capital protection against sharp drawdowns.